The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Adoptive Cell Therapy-Global Market Insights and Sales Trends 2024
Synopsis
Adoptive cell therapy, also known as cellular immunotherapy, is a form of treatment that uses the cells of our immune system to eliminate cancer.
The global Adoptive Cell Therapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Adoptive Cell Therapy in various end use industries. The expanding demands from the Lymphoma and Leukemia, are propelling Adoptive Cell Therapy market. CAR-T, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the TCR-T segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Adoptive Cell Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Adoptive Cell Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Adoptive Cell Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Adoptive Cell Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Adoptive Cell Therapy covered in this report include Novartis, Juno, Kite, Adaptimmune, Fibrocell, Lineage Cell Therapeutics, BioTime, Vericel Corporation and Regeneus, etc.
The global Adoptive Cell Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Juno
Kite
Adaptimmune
Fibrocell
Lineage Cell Therapeutics
BioTime
Vericel Corporation
Regeneus
Anhui Anke Biotechnology
Cellectis
NantKwest
SorrentoTherapeutics
Bellicum
Global Adoptive Cell Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Adoptive Cell Therapy market, Segment by Type:
CAR-T
TCR-T
NK
TIL
Global Adoptive Cell Therapy market, by Application
Lymphoma
Leukemia
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Adoptive Cell Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Adoptive cell therapy, also known as cellular immunotherapy, is a form of treatment that uses the cells of our immune system to eliminate cancer.
The global Adoptive Cell Therapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Adoptive Cell Therapy in various end use industries. The expanding demands from the Lymphoma and Leukemia, are propelling Adoptive Cell Therapy market. CAR-T, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the TCR-T segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Adoptive Cell Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Adoptive Cell Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Adoptive Cell Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Adoptive Cell Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Adoptive Cell Therapy covered in this report include Novartis, Juno, Kite, Adaptimmune, Fibrocell, Lineage Cell Therapeutics, BioTime, Vericel Corporation and Regeneus, etc.
The global Adoptive Cell Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Juno
Kite
Adaptimmune
Fibrocell
Lineage Cell Therapeutics
BioTime
Vericel Corporation
Regeneus
Anhui Anke Biotechnology
Cellectis
NantKwest
SorrentoTherapeutics
Bellicum
Global Adoptive Cell Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Adoptive Cell Therapy market, Segment by Type:
CAR-T
TCR-T
NK
TIL
Global Adoptive Cell Therapy market, by Application
Lymphoma
Leukemia
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Adoptive Cell Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Adoptive Cell Therapy
1.1 Adoptive Cell Therapy Market Overview
1.1.1 Adoptive Cell Therapy Product Scope
1.1.2 Adoptive Cell Therapy Market Status and Outlook
1.2 Global Adoptive Cell Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Adoptive Cell Therapy Market Size by Region (2018-2029)
1.4 Global Adoptive Cell Therapy Historic Market Size by Region (2018-2023)
1.5 Global Adoptive Cell Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Adoptive Cell Therapy Market Size (2018-2029)
1.6.1 North America Adoptive Cell Therapy Market Size (2018-2029)
1.6.2 Europe Adoptive Cell Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific Adoptive Cell Therapy Market Size (2018-2029)
1.6.4 Latin America Adoptive Cell Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa Adoptive Cell Therapy Market Size (2018-2029)
2 Adoptive Cell Therapy Market by Type
2.1 Introduction
2.1.1 CAR-T
2.1.2 TCR-T
2.1.3 NK
2.1.4 TIL
2.2 Global Adoptive Cell Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Adoptive Cell Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Adoptive Cell Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Adoptive Cell Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Adoptive Cell Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Adoptive Cell Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Adoptive Cell Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Adoptive Cell Therapy Revenue Breakdown by Type (2018-2029)
3 Adoptive Cell Therapy Market Overview by Application
3.1 Introduction
3.1.1 Lymphoma
3.1.2 Leukemia
3.2 Global Adoptive Cell Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Adoptive Cell Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Adoptive Cell Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Adoptive Cell Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Adoptive Cell Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Adoptive Cell Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Adoptive Cell Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Adoptive Cell Therapy Revenue Breakdown by Application (2018-2029)
4 Adoptive Cell Therapy Competition Analysis by Players
4.1 Global Adoptive Cell Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Adoptive Cell Therapy as of 2022)
4.3 Date of Key Players Enter into Adoptive Cell Therapy Market
4.4 Global Top Players Adoptive Cell Therapy Headquarters and Area Served
4.5 Key Players Adoptive Cell Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Adoptive Cell Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novartis
5.1.1 Novartis Profile
5.1.2 Novartis Main Business
5.1.3 Novartis Adoptive Cell Therapy Products, Services and Solutions
5.1.4 Novartis Adoptive Cell Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Novartis Recent Developments
5.2 Juno
5.2.1 Juno Profile
5.2.2 Juno Main Business
5.2.3 Juno Adoptive Cell Therapy Products, Services and Solutions
5.2.4 Juno Adoptive Cell Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Juno Recent Developments
5.3 Kite
5.3.1 Kite Profile
5.3.2 Kite Main Business
5.3.3 Kite Adoptive Cell Therapy Products, Services and Solutions
5.3.4 Kite Adoptive Cell Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Adaptimmune Recent Developments
5.4 Adaptimmune
5.4.1 Adaptimmune Profile
5.4.2 Adaptimmune Main Business
5.4.3 Adaptimmune Adoptive Cell Therapy Products, Services and Solutions
5.4.4 Adaptimmune Adoptive Cell Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Adaptimmune Recent Developments
5.5 Fibrocell
5.5.1 Fibrocell Profile
5.5.2 Fibrocell Main Business
5.5.3 Fibrocell Adoptive Cell Therapy Products, Services and Solutions
5.5.4 Fibrocell Adoptive Cell Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Fibrocell Recent Developments
5.6 Lineage Cell Therapeutics
5.6.1 Lineage Cell Therapeutics Profile
5.6.2 Lineage Cell Therapeutics Main Business
5.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Products, Services and Solutions
5.6.4 Lineage Cell Therapeutics Adoptive Cell Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 Lineage Cell Therapeutics Recent Developments
5.7 BioTime
5.7.1 BioTime Profile
5.7.2 BioTime Main Business
5.7.3 BioTime Adoptive Cell Therapy Products, Services and Solutions
5.7.4 BioTime Adoptive Cell Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 BioTime Recent Developments
5.8 Vericel Corporation
5.8.1 Vericel Corporation Profile
5.8.2 Vericel Corporation Main Business
5.8.3 Vericel Corporation Adoptive Cell Therapy Products, Services and Solutions
5.8.4 Vericel Corporation Adoptive Cell Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Vericel Corporation Recent Developments
5.9 Regeneus
5.9.1 Regeneus Profile
5.9.2 Regeneus Main Business
5.9.3 Regeneus Adoptive Cell Therapy Products, Services and Solutions
5.9.4 Regeneus Adoptive Cell Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 Regeneus Recent Developments
5.10 Anhui Anke Biotechnology
5.10.1 Anhui Anke Biotechnology Profile
5.10.2 Anhui Anke Biotechnology Main Business
5.10.3 Anhui Anke Biotechnology Adoptive Cell Therapy Products, Services and Solutions
5.10.4 Anhui Anke Biotechnology Adoptive Cell Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 Anhui Anke Biotechnology Recent Developments
5.11 Cellectis
5.11.1 Cellectis Profile
5.11.2 Cellectis Main Business
5.11.3 Cellectis Adoptive Cell Therapy Products, Services and Solutions
5.11.4 Cellectis Adoptive Cell Therapy Revenue (US$ Million) & (2018-2023)
5.11.5 Cellectis Recent Developments
5.12 NantKwest
5.12.1 NantKwest Profile
5.12.2 NantKwest Main Business
5.12.3 NantKwest Adoptive Cell Therapy Products, Services and Solutions
5.12.4 NantKwest Adoptive Cell Therapy Revenue (US$ Million) & (2018-2023)
5.12.5 NantKwest Recent Developments
5.13 SorrentoTherapeutics
5.13.1 SorrentoTherapeutics Profile
5.13.2 SorrentoTherapeutics Main Business
5.13.3 SorrentoTherapeutics Adoptive Cell Therapy Products, Services and Solutions
5.13.4 SorrentoTherapeutics Adoptive Cell Therapy Revenue (US$ Million) & (2018-2023)
5.13.5 SorrentoTherapeutics Recent Developments
5.14 Bellicum
5.14.1 Bellicum Profile
5.14.2 Bellicum Main Business
5.14.3 Bellicum Adoptive Cell Therapy Products, Services and Solutions
5.14.4 Bellicum Adoptive Cell Therapy Revenue (US$ Million) & (2018-2023)
5.14.5 Bellicum Recent Developments
6 North America
6.1 North America Adoptive Cell Therapy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Adoptive Cell Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Adoptive Cell Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Adoptive Cell Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Adoptive Cell Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Adoptive Cell Therapy Market Dynamics
11.1 Adoptive Cell Therapy Industry Trends
11.2 Adoptive Cell Therapy Market Drivers
11.3 Adoptive Cell Therapy Market Challenges
11.4 Adoptive Cell Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
